CMS Looks To End Pharma Co.'s Drug Classification Suit

By Kevin Stawicki (March 20, 2019, 7:01 PM EDT) -- A regulatory change in 2016 didn't require the Centers for Medicare & Medicaid Services to retroactively reclassify STI Pharma LLC's antibiotic Sulfatrim as a "non-innovator" generic that carried a lower rebate rate for the drugmaker, the Department of Health and Human Services has told a federal court....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!